Clinical Core
Marilyn Bulloch, PharmD, BCPS, SPP
Associate Clinical Professor and Director of Strategic Operations
Auburn University Harrison School of Pharmacy
Kimberly, Alabama
Disclosure(s): No relevant financial relationship(s) to disclose.
Recent attention has focused on tasks we do in healthcare for no good reason or because "that's the way we were trained to do it." While critical care specialists generally hold evidence-based practice as the gold standard, some medications seem to be prescribed almost reflexively in the ICU patient. Although evidence supports the use of these medications, the evidence may not be conclusive or persuasive. In some areas, emerging evidence suggests that prescribing practices that have become almost second nature may not be as beneficial as once believed. This session will focus on five common medications or therapeutic groups and evaluate evidence to support or refute their routine use in the ICU: bronchodilators, empiric anaerobic coverage in pneumonia, preventative bowel regimens in patients not on opioids, maintenance IV fluids, and antipsychotics for ICU delirium.
Concurrent Session Faculty: Richard D. Branson, MS, RRT, FCCM – University of Cincinnati Medical Center
Concurrent Session Faculty: Kevin Betthauser, BCCCP, PharmD (he/him/his) – Barnes Jewish Hospital
Concurrent Session Faculty: Melissa Santibanez, BCCCP, PharmD, (she/her/hers) – n/a
Concurrent Session Faculty: W. Anthony A. Hawkins, BCCCP, PharmD, FCCM – UGA College of Pharmacy
Concurrent Session Faculty: Madissen Humphries, PharmD, – DCH Regional Medical Center